Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lidocaine Ineffectiveness in ADHD and PMS
NCT03676725Phase 1Completed
- Sponsor
- PhenoSolve
- Start
- Aug 2019
- Primary completion
- Mar 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, double-blind, single-arm trial of lidocaine 10% oropharyngeal spray in pain, sponsored by PhenoSolve. Primary endpoint: Number of Subjects With Lidocaine Ineffectiveness at 30 minutes. Started Aug 2019; status: completed.
02
Drugs
lidocaine 10% oropharyngeal spray
03
Conditions
pain
Beyond the preview
Go deeper on NCT03676725.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03676725.